New 5-modified pyrimidine nucleoside inhibitors of mycobacterial growth.
The WHO has declared tuberculosis (TB) a global health emergency. Therefore, there is an urgent need to discover and develop new anti-TB drugs. Here we report on a new category of 5-substituted pyrimidine nucleosides as potent inhibitors of Myco-bacterium tuberculosis growth in vitro. A series of 2'-deoxy-, 3'-azido-2',3'-dideoxy-, and 3'-amino-2',3'-dideoxypyrimidine nucleoside analogues bearing lengthy flexible alkyloxymethyl substituents exhibited marked inhibitory activity against M. tuberculosis in vitro. 5-Dodecyloxymethyl-2'-deoxyuridine was found to be a potent inhibitor of M. tuberculosis propagation in vitro. In contrast, monophosphates of the tested nucleosides were devoid of antimycobacterial activity. This new class of inhibitors seems to be a promising chemotherapeutic agent against TB and merits further studies.
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences.
L A
LA
Alexandrova
E R
ER
Shmalenyuk
S N
SN
Kochetkov
V V
VV
Erokhin
T G
TG
Smirnova
S N
SN
Andreevskaia
L N
LN
Chernousova